Dendritic Cell-Based Vaccine for the Treatment of Malignant Glioma: A Systematic Review
作者： Xuan Wang , Hong-Yang Zhao , Fang-Cheng Zhang , Yun Sun , Zhi-Yong Xiong
DOI: 10.3109/07357907.2014.958234
关键词: Glioblastoma 、 Dendritic cell 、 Immunotherapy 、 Comparative trial 、 Poor prognosis 、 Immunology 、 Oncology 、 Internal medicine 、 Clinical trial 、 Glioma 、 Medicine 、 Survival rate
摘要: Objective: Glioblastoma multiforme (GBM) has a poor prognosis. The purpose of this systematic review and meta-analysis was to analyze the outcomes clinical trials which compared immunotherapy with conventional therapy for treatment malignant gliomas. Methods: PubMed, Cochrane Google Scholar databases were searched relevant studies. 2-year survival rate used evaluate effectiveness immunotherapy. Results: Of 171 studies identified, six comparative included in review. Immunotherapy associated significantly longer OS therapy. Conclusion: may improve patients GBM.
sci-hub.se 参考文章(40)
Seunggu J. Han, Corinna Zygourakis, Michael Lim, Andrew T. Parsa, Immunotherapy for Glioma: Promises and Challenges Neurosurgery Clinics of North America. ,vol. 23, pp. 357- 370 ,(2012) , 10.1016/J.NEC.2012.05.001
David N. Louis, WHO classification of tumours of the central nervous system International Agency for Research on Cancer. ,(2007)
Michael A. Vogelbaum, John H. Sampson, Sandeep Kunwar, Susan M. Chang, Mark Shaffrey, Anthony L. Asher, Frederick F. Lang, David Croteau, Kristen Parker, Amy Y. Grahn, Jeffrey W. Sherman, S. Rafat Husain, Raj K. Puri, Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. Neurosurgery. ,vol. 61, pp. 1031- 1037 ,(2007) , 10.1227/01.NEU.0000303199.77370.9E
Kevin Bielamowicz, Shumaila Khawja, Nabil Ahmed, Adoptive cell therapies for glioblastoma. Frontiers in Oncology. ,vol. 3, pp. 275- 275 ,(2013) , 10.3389/FONC.2013.00275
Zvi Lidar, Yael Mardor, Tali Jonas, Raphael Pfeffer, Meir Faibel, Dvora Nass, Moshe Hadani, Zvi Ram, Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. Journal of Neurosurgery. ,vol. 100, pp. 472- 479 ,(2004) , 10.3171/JNS.2004.100.3.0472
Prahlad Parajuli, Saroj Mathupala, Andrew E. Sloan, Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas: in vitro induction of cytolytic and natural killer-like T cells. Neurosurgery. ,vol. 55, pp. 1194- 1204 ,(2004) , 10.1227/01.NEU.0000141082.20865.48
Surasak Phuphanich, Christopher J. Wheeler, Jeremy D. Rudnick, Mia Mazer, HongQian Wang, Miriam A. Nuño, Jaime E. Richardson, Xuemo Fan, Jianfei Ji, Ray M. Chu, James G. Bender, Elma S. Hawkins, Chirag G. Patil, Keith L. Black, John S. Yu, Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma Cancer Immunology, Immunotherapy. ,vol. 62, pp. 125- 135 ,(2013) , 10.1007/S00262-012-1319-0
Taizo Nitta, Hideo Yagita, Ko Okumura, Kiyoshi Sato, Shozo Ishii, Preliminary trial of specific targeting therapy against malignant glioma The Lancet. ,vol. 335, pp. 368- 371 ,(1990) , 10.1016/0140-6736(90)90205-J
Robert M. Prins, Xiaoyan Wang, Horacio Soto, Emma Young, Dominique N. Lisiero, Brendan Fong, Richard Everson, William H. Yong, Albert Lai, Gang Li, Timothy F. Cloughesy, Linda M. Liau, Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients Journal of Immunotherapy. ,vol. 36, pp. 152- 157 ,(2013) , 10.1097/CJI.0B013E3182811AE4
Shigeo Koido, Sadamu Homma, Masato Okamoto, Yoshihisa Namiki, Kazuki Takakura, Kan Uchiyama, Mikio Kajihara, Seiji Arihiro, Hiroo Imazu, Hiroshi Arakawa, Shin Kan, Hideo Komita, Masaki Ito, Toshifumi Ohkusa, Jianlin Gong, Hisao Tajiri, Fusions between dendritic cells and whole tumor cells as anticancer vaccines OncoImmunology. ,vol. 2, ,(2013) , 10.4161/ONCI.24437